Search Results - "Seror, Raphaële"
-
1
Current and future therapies for primary Sjögren syndrome
Published in Nature reviews. Rheumatology (01-08-2021)“…Primary Sjögren syndrome (pSS) is a systemic autoimmune disease that is characterized by a triad of symptoms that affect all patients (dryness, pain and…”
Get full text
Journal Article -
2
18F-FDG PET molecular imaging: A relevant tool to investigate chronic inflammatory rheumatisms in clinical practice?
Published in Frontiers in medicine (30-11-2022)“…18 F-Labeled Fluorodeoxyglucose-Positron Emission Tomography ( 18 F-FDG PET) is a molecular imaging tool commonly used in practice for the assessment of many…”
Get full text
Journal Article -
3
Cancer screening in chronic inflammatory rheumatic diseases
Published in Joint, bone, spine : revue du rhumatisme (01-07-2023)“…Cancer is a major public health concern, and screening for cancer is a on-going issue in our practice. The risk of cancer in patients with chronic inflammatory…”
Get full text
Journal Article -
4
2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus
Published in Annals of the rheumatic diseases (01-09-2019)“…To develop new classification criteria for systemic lupus erythematosus (SLE) jointly supported by the European League Against Rheumatism (EULAR) and the…”
Get more information
Journal Article -
5
Outcome Measures in Primary Sjögren’s Syndrome
Published in Arthritis care & research (2010) (01-10-2020)Get full text
Journal Article -
6
2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data‐Driven Methodology Involving Three International Patient Cohorts
Published in Arthritis & rheumatology (Hoboken, N.J.) (01-01-2017)“…Objective To develop and validate an international set of classification criteria for primary Sjögren's syndrome (SS) using guidelines from the American…”
Get full text
Journal Article Conference Proceeding -
7
2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome: A consensus and data-driven methodology involving three international patient cohorts
Published in Annals of the rheumatic diseases (01-01-2017)“…To develop and validate an international set of classification criteria for primary Sjögren's syndrome (SS) using guidelines from the American College of…”
Get more information
Journal Article -
8
Epidemiology of Sjögren syndrome
Published in Nature reviews. Rheumatology (01-03-2024)“…Sjögren syndrome is a phenotypically varied autoimmune disorder that can occur alone in primary Sjögren syndrome or in association with other connective tissue…”
Get full text
Journal Article -
9
Efficacy and safety of belimumab in primary Sjögren's syndrome: results of the BELISS open-label phase II study
Published in Annals of the rheumatic diseases (01-03-2015)“…Increased expression of B cell activating factor (BAFF or B lymphocyte stimulator) may explain the B cell activation characteristic of primary Sjögren's…”
Get more information
Journal Article -
10
EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome
Published in Annals of the rheumatic diseases (01-06-2010)“…To develop a disease activity index for patients with primary Sjögren's syndrome (SS): the European League Against Rheumatism (EULAR) Sjögren's syndrome…”
Get more information
Journal Article -
11
Malignancy and the Risks of Biologic Therapies: Current Status
Published in Rheumatic diseases clinics of North America (01-02-2017)“…Cancer is a common event in patients with rheumatic diseases. In some cases, the disease, its risk factors, or its treatment could play a role in favoring…”
Get full text
Journal Article -
12
Characterization of systemic disease in primary Sjögren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements
Published in Rheumatology (Oxford, England) (01-12-2015)“…To reach a European consensus on the definition and characterization of the main organ-specific extraglandular manifestations in primary SS. The EULAR-SS Task…”
Get full text
Journal Article Conference Proceeding -
13
Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force
Published in Annals of the rheumatic diseases (01-06-2016)“…There is convincing evidence for the known and unambiguously accepted beneficial effects of glucocorticoids at low dosages. However, the implementation of…”
Get more information
Journal Article -
14
Cost-effectiveness of rituximab strategies in rheumatoid arthritis
Published in The Lancet (British edition) (28-01-2017)“…We read with interest the Article by Duncan Porter and colleagues (July 16, p 239), 1 and the accompanying comment by Tom Huizinga and colleagues (July 16, p…”
Get full text
Journal Article -
15
EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies
Published in Annals of the rheumatic diseases (01-01-2020)“…The therapeutic management of Sjögren syndrome (SjS) has not changed substantially in recent decades: treatment decisions remain challenging in clinical…”
Get more information
Journal Article -
16
Efficacy and safety of belimumab given for 12 months in primary Sjögren's syndrome: the BELISS open-label phase II study
Published in Rheumatology (Oxford, England) (01-12-2015)“…To report the efficacy and safety of long-term treatment of SS with belimumab, targeting the B-cell-activating factor. Patients with primary SS were included…”
Get full text
Journal Article -
17
Rituximab Impairs B Cell Response But Not T Cell Response to COVID‐19 Vaccine in Autoimmune Diseases
Published in Arthritis & rheumatology (Hoboken, N.J.) (01-06-2022)“…Objective Antibody response to the messenger RNA (mRNA) COVID‐19 vaccine has been shown to be diminished in rituximab (RTX)–treated patients. We undertook this…”
Get full text
Journal Article -
18
Inflammation-targeted therapies and cancer
Published in Joint, bone, spine : revue du rhumatisme (01-07-2021)“…•Data are reassuring regarding the overall risk of cancer with TNF inhibitors (TNFi).•The risk of lymphoma does not seem to be increased with TNFi.•There is…”
Get full text
Journal Article -
19
Disease activity and patient reported outcome measures in Sjögren's - what are the best tools to evaluate?
Published in Rheumatology (Oxford, England) (02-08-2021)“…In primary SS (pSS), clinical features in SS can be divided into two facets: the patient perceived manifestations such as dryness, pain and fatigue, and the…”
Get full text
Journal Article -
20
Arthritis in primary Sjögren's syndrome: Characteristics, outcome and treatment from French multicenter retrospective study
Published in Autoimmunity reviews (01-01-2019)“…To describe the characteristics and the outcome of primary Sjögren Syndrome (pSS) associated arthritis and to compare the efficacy of different therapeutic…”
Get full text
Journal Article